Table:
begin	end	state
1	14	non-cytoplasmic
15	34	transmembrane
35	41	cytoplasmic
42	75	transmembrane
76	86	non-cytoplasmic
87	106	transmembrane
107	117	cytoplasmic
118	136	transmembrane
137	141	non-cytoplasmic
142	161	transmembrane
162	172	cytoplasmic
173	193	transmembrane
194	212	non-cytoplasmic
213	235	transmembrane
236	254	cytoplasmic
255	273	transmembrane
274	284	non-cytoplasmic
285	304	transmembrane
305	315	cytoplasmic
316	339	transmembrane
340	349	non-cytoplasmic
350	368	transmembrane
369	374	cytoplasmic
375	394	transmembrane
395	395	non-cytoplasmic
396	422	transmembrane
423	435	cytoplasmic
436	455	transmembrane
456	456	non-cytoplasmic

Input:
>WP_044623468.1 NCBI__GCF_000940995.1:WP_044623468.1
MTALTMTLRKWLFDRNSIILLADIALFTLLLNTLPFDREVVVGLSILAFVAVLWLTEALH
VSITAILVPILAVSFDIFPTPAALSNFANPIIFLFLGGFALAAALHKQELDKAIADKVLL
IAQGRMSVAVFMLFGVSAALSMWISNTATTAMMLPLVLGVLNKVNAKSERSTYVFVLLGI
AYCASIGGIATVVGSPPNAIAAAEVGLSFTEWMAFGLPVSIVLLPVTVALLYFMLKPNLN
HTFELDHKPVEWNNGKLATLAIFAITVLLWIFSKPINGMLGGFKSFDTLVALAAIVMLGA
SRVVQWKDIEKSTDWGVLLLFGGGICLSNVLKATGTSVFLAHSLSGFLEQAGLFFTILVV
AGFVVFLTEFASNTASAALLVPVFATVAEALGVSPVILSALIAVAASCAFMLPVATPPNA
IVFGSGHIKQSDMMKVGIYLNILCIAVLSALAYLFW

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server